Shawna Pandya, an Indian-origin physician and bioastronautics researcher, will be part of Virgin Galactic’s upcoming space research mission. This mission, a collaboration between Richard Branson’s Virgin Galactic and the International Institute for Astronautical Sciences (IIAS), will be conducted aboard the Delta Class spaceship.

Pandya, a prominent figure in space medicine and Director of IIAS’ Space Medicine Group, joins a distinguished crew for this second research mission. The team includes Kellie Gerardi, Director of Human Spaceflight Operations at IIAS, and Norah Patten, an aeronautical engineer from Ireland. The mission follows the success of the ‘Galactic 05’ mission in November 2023, which tested novel healthcare technologies and analyzed fluid dynamics in microgravity to aid the design of future medical technologies and life-support systems.

Pandya, who has extensive experience in space research, was part of the first crew to test a commercial spacesuit in zero gravity in 2015. Her impressive record includes flying in 10 parabolic flight campaigns, amassing over 160 parabolas in micro- and reduced gravity conditions.

“We were thrilled with the results from our fluid cell experiment on ‘Galactic 05’, which demonstrated our ability to accurately predict fluid behavior in a weightless environment”, said Gerardi, reflecting on the mission’s success.

Sirisha Bandla, Virgin Galactic’s Vice President of Government Affairs and Research, emphasized the ongoing collaboration with IIAS. “We’re excited to continue our partnership with IIAS in an expanded capacity”, said Bandla, who flew on the ‘Unity 22’ spaceflight, becoming the second Indian-born woman to travel to space.

This mission highlights the growing role of Indian-origin researchers in advancing space science and technology, further solidifying international collaborations in space exploration.

source/content: siliconindia.com (headline edited)